Two meanings of reverse vaccinology and the empirical nature of vaccine science

Vaccine

Volumn 29, Issue 45, 2011, Pages 7875-

  Van Regenmortel, Marc H V ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VACCINE; VIRUS ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN BINDING; BACTERIAL GENOME; BACTERICIDAL ACTIVITY; COMPUTER MODEL; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOLOGY; LETTER; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE VACCINOLOGY; VACCINATION;

ANIMALS; ANTIGENS; EPITOPES; GENETIC ENGINEERING; HUMANS; MOLECULAR BIOLOGY; VACCINES;

EID: 80053638380     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.063     Document Type: Letter

References (6)

1. KarlssonHedestam G.B., Fouchier R.A., Phogat S., Burton D.R., Sodroski J., Wyatt R.T. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 2008, 6:143-155.
2. Vaccine design: innovative approaches and novel strategies 2011, Caister Acad. Press, Norfolk, UK. R. Rappuoli, Bagnoli F (Eds.).
3. Burton D.R. Antibodies, viruses and vaccines. Nat Rev Immunol 2002, 2:706-713.
4. Burton D.R. Scaffolding to build a rational vaccine design strategy. Proc Natl Acad Sci U S A 2010, 107:17859-17860.
5. Van Regenmortel M.H.V. Limitations to the structure-based design of HIV-1 vaccine immunogens. J Mol Recogn 2011, 24:741-753.
6. Mascola J.R. Herpes simplex virus vaccines - why don't antibodies protect?. J Am Med Assoc 1999, 281:379-380.